MARKET

BCPC

BCPC

Balchem Corp
NASDAQ
128.02
+1.50
+1.19%
Closed 16:01 12/05 EST
OPEN
126.72
PREV CLOSE
126.52
HIGH
128.09
LOW
125.23
VOLUME
106.76K
TURNOVER
0
52 WEEK HIGH
143.68
52 WEEK LOW
110.74
MARKET CAP
4.13B
P/E (TTM)
40.19
1D
5D
1M
3M
1Y
5Y
Balchem Corp: Current report
Press release · 21h ago
Balchem raises annual dividend by 11.3% to $0.79/share
Balchem raises annual dividend by 11.3% to $0.79/share. Forward yield 0.62% and ex-div is 0.71%. Balchem corporation declares $ 0.79 annual dividend for shareholders of record dec. 27; ex-dividend is jan. 19.
Seeking Alpha · 22h ago
Balchem Corporation (NASDAQ:BCPC) is favoured by institutional owners who hold 89% of the company
Institutional investors own 89% of balchem corporation (nasdaq:bcpc) with a large chunk of the company. The company has a large number of large shareholders, but the average insider ownership level is low. Blackrock, inc. Is the largest shareholder of the firm. Balchem is not owned by hedge funds, but there are some notable signs of insider selling. The insider could be a bad influence on the company's future. Check out the history of insider ownership in balchem and the company itself.
Simply Wall St · 2d ago
Weekly Report: what happened at BCPC last week (1127-1201)?
Weekly Report · 2d ago
Mastercard, Pfizer Among 18 Companies To Announce Dividend Increases In December
Mastercard, pfizer among 18 companies to announce their annual dividend increases in december. Broadcom and mastercard are among the companies expected to announce increases in the second half of november. Nike's annual dividend increase was announced in the middle of november, but will be deferred to december. I predict 16 other companies will announce dividend increases before christmas.
Seeking Alpha · 11/27 15:44
Weekly Report: what happened at BCPC last week (1120-1124)?
Weekly Report · 11/27 09:32
Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)
Balchem corporation (nasdaq:bcpc) is estimated to have a fair value of us$109. The discounted cash flow method is used to estimate a company's intrinsic value. Balchem's share price is trading at similar levels to its fair value estimate. Analyst price target for balchem is us$145, which is 34% above the stock's fair value.
Simply Wall St · 11/20 15:19
Weekly Report: what happened at BCPC last week (1113-1117)?
Weekly Report · 11/20 09:32
More
About BCPC
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. The Company’s segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also serves the food and beverage industry for beverage, bakery, dairy, confectionary, and savory manufacturers. The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies, in addition to nutrient choline chloride. Through Specialty Products, it provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market.

Webull offers Balchem Corp stock information, including NASDAQ: BCPC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BCPC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BCPC stock methods without spending real money on the virtual paper trading platform.